- Home
- RNP vs OPK Comparison
RNP vs OPK Comparison
Compare RNP & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNP
- OPK
- Stock Information
- Founded
- RNP 2003
- OPK 2007
- Country
- RNP United States
- OPK United States
- Employees
- RNP N/A
- OPK N/A
- Industry
- RNP Investment Managers
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- RNP Finance
- OPK Health Care
- Exchange
- RNP Nasdaq
- OPK Nasdaq
- Market Cap
- RNP 1.0B
- OPK 989.0M
- IPO Year
- RNP N/A
- OPK 1995
- Fundamental
- Price
- RNP $21.47
- OPK $1.49
- Analyst Decision
- RNP
- OPK Strong Buy
- Analyst Count
- RNP 0
- OPK 3
- Target Price
- RNP N/A
- OPK $2.75
- AVG Volume (30 Days)
- RNP 117.6K
- OPK 2.9M
- Earning Date
- RNP 01-01-0001
- OPK 02-25-2025
- Dividend Yield
- RNP 7.94%
- OPK N/A
- EPS Growth
- RNP N/A
- OPK N/A
- EPS
- RNP N/A
- OPK N/A
- Revenue
- RNP N/A
- OPK $711,408,000.00
- Revenue This Year
- RNP N/A
- OPK N/A
- Revenue Next Year
- RNP N/A
- OPK $0.00
- P/E Ratio
- RNP N/A
- OPK N/A
- Revenue Growth
- RNP N/A
- OPK N/A
- 52 Week Low
- RNP $15.52
- OPK $0.86
- 52 Week High
- RNP $21.27
- OPK $1.76
- Technical
- Relative Strength Index (RSI)
- RNP 56.74
- OPK 44.74
- Support Level
- RNP $20.17
- OPK $1.45
- Resistance Level
- RNP $21.11
- OPK $1.51
- Average True Range (ATR)
- RNP 0.30
- OPK 0.06
- MACD
- RNP 0.17
- OPK 0.00
- Stochastic Oscillator
- RNP 97.89
- OPK 33.33
About RNP Cohen & Steers REIT and Preferred and Income Fund Inc.
Cohen & Steers REIT and Preferred Income Fund Inc is a diversified, closed-ended investment management fund. Its investment objective is to provide high current income with capital appreciation as its secondary objective. The Fund invests at least its total assets in common stocks issued by real estate investment trusts (REITs) and preferred securities under normal circumstances.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.